发明名称 |
VEGF Antagonist Formulations |
摘要 |
Formulations of a vascular endothelial growth factor (VEGF)-specific fusion protein antagonist are provided including a pre-lyophilized formulation, a reconstituted lyophilized formulation, and a stable liquid formulation. Preferably, the fusion protein has the sequence of SEQ ID NO:4. |
申请公布号 |
US2012101035(A1) |
申请公布日期 |
2012.04.26 |
申请号 |
US201213343214 |
申请日期 |
2012.01.04 |
申请人 |
DIX DANIEL;FRYE KELLY;KAUTZ SUSAN;REGENERON PHARMACEUTICALS, INC. |
发明人 |
DIX DANIEL;FRYE KELLY;KAUTZ SUSAN |
分类号 |
A61K38/18;A61P43/00 |
主分类号 |
A61K38/18 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|